(PHEQ) Morgan Stanley Trust - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US61774R8741 • Equity Hedged
PHEQ: Large Caps, Equity, Options, Trading, Stocks
The Morgan Stanley ETF Trust (NYSE ARCA: PHEQ) is designed to generate long-term capital appreciation by focusing on large-capitalization U.S. companies. The fund achieves this by investing in equity securities of firms that are part of the Solactive GBS U.S. 500 Index at the time of purchase. This index serves as a benchmark for the performance of 500 of the largest U.S. companies, providing a diversified exposure to the U.S. equity market. The fund employs a passive management strategy, aiming to replicate the performance of the underlying index by holding a representative sample of its constituents.
As an exchange-traded fund (ETF), PHEQ offers investors the flexibility to trade throughout the day on the NYSE ARCA exchange, combining the diversification benefits of a mutual fund with the tradability of individual stocks. The fund is categorized as an Equity Hedged ETF, which typically involves the use of derivatives to hedge against market risks, though the specific hedging strategies employed by PHEQ are not explicitly detailed in the provided data.
From a technical perspective, PHEQ has shown a recent price of $29.46, with short-term moving averages indicating a potential downtrend. The 20-day SMA of $30.13 and 50-day SMA of $29.91 suggest that the funds price has dipped slightly below its recent averages. The 200-day SMA of $28.62 indicates a longer-term uptrend, as the current price remains above this level. The Average True Range (ATR) of 0.22 reflects relatively low volatility, suggesting that the funds price movements have been stable in recent trading sessions.
In terms of fundamental analysis, the funds assets under management (AUM) of $88.51 million indicate a moderate size, which is sufficient to maintain liquidity while avoiding excessive market impact. The average daily trading volume of 9,052 shares further underscores the funds relatively low trading activity, which may appeal to investors seeking stability over high turnover.
Over the next three months, PHEQ is expected to experience a slight decline in price based on its technical indicators. The 20-day SMA crossing below the 50-day SMA suggests a potential short-term bearish trend. However, the 200-day SMA remaining above the current price indicates that the long-term outlook remains positive. With an ATR of 0.22, volatility is expected to remain low, leading to a forecasted price range of $29.00 to $30.50. The funds AUM of $88.51 million and average daily volume of 9,052 shares suggest that liquidity will remain stable, supporting consistent trading activity.
Additional Sources for PHEQ ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PHEQ ETF Overview
Market Cap in USD | 87m |
Category | Equity Hedged |
TER | 0.29% |
IPO / Inception | 2023-10-16 |
PHEQ ETF Ratings
Growth Rating | 49.0 |
Fundamental | - |
Dividend Rating | 16.8 |
Rel. Strength | -4.32 |
Analysts | - |
Fair Price Momentum | 25.59 USD |
Fair Price DCF | - |
PHEQ Dividends
Dividend Yield 12m | 1.50% |
Yield on Cost 5y | 1.79% |
Annual Growth 5y | -4.21% |
Payout Consistency | 95.7% |
PHEQ Growth Ratios
Growth Correlation 3m | -88.5% |
Growth Correlation 12m | 68.4% |
Growth Correlation 5y | 90.9% |
CAGR 5y | 12.07% |
CAGR/Max DD 5y | 0.96 |
Sharpe Ratio 12m | 1.43 |
Alpha | -1.31 |
Beta | 0.541 |
Volatility | 23.05% |
Current Volume | 50.1k |
Average Volume 20d | 11.7k |
As of May 01, 2025, the stock is trading at USD 28.43 with a total of 50,125 shares traded.
Over the past week, the price has changed by +2.17%, over one month by -0.62%, over three months by -5.39% and over the past year by +7.04%.
Partly, yes. Based on ValueRay Analyses, Morgan Stanley Trust (NYSE ARCA:PHEQ) is currently (May 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 48.96 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PHEQ as of May 2025 is 25.59. This means that PHEQ is currently overvalued and has a potential downside of -9.99%.
Morgan Stanley Trust has no consensus analysts rating.
According to ValueRays Forecast Model, PHEQ Morgan Stanley Trust will be worth about 28.5 in May 2026. The stock is currently trading at 28.43. This means that the stock has a potential upside of +0.21%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 28.5 | 0.2% |